* ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. SECOND...The Collaboration Agreement • November 15th, 2002 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Second Amendment to the Collaboration Agreement (“Second Amendment”) is made and entered into on September 16, 2002 (the “Amendment Date”), by and between ONYX PHARMACEUTICALS, INC., a Delaware corporation having its principal place of business at 3031 Research Drive, Richmond, California 94806 (“Onyx”) and WARNER-LAMBERT COMPANY, a Delaware corporation and a wholly-owned subsidiary of Pfizer Inc. having a place of business at 2800 Plymouth Road, Ann Arbor, MI 48105 (“Warner”).
